These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 25153169)

  • 1. Evaluation of prognostic integrin α2β1 PET tracer and concurrent targeting delivery using focused ultrasound for brain glioma detection.
    Chung YH; Hsu PH; Huang CW; Hsieh WC; Huang FT; Chang WC; Chiu H; Hsu ST; Yen TC
    Mol Pharm; 2014 Nov; 11(11):3904-14. PubMed ID: 25153169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of PET Imaging for Prognostic Integrin α
    Huang CW; Hsieh WC; Hsu ST; Lin YW; Chung YH; Chang WC; Chiu H; Lin YH; Wu CP; Yen TC; Huang FT
    Theranostics; 2017; 7(16):4013-4028. PubMed ID: 29109795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evaluation of
    Liu Q; Cai S; Ye J; Xie Q; Liu R; Qiu L; Lin J
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1826-1840. PubMed ID: 38319321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
    Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A
    Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
    Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
    J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of two novel ⁶⁴Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ₃.
    Hernandez R; Czerwinski A; Chakravarty R; Graves SA; Yang Y; England CG; Nickles RJ; Valenzuela F; Cai W
    Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1859-68. PubMed ID: 26016906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved positron emission tomography imaging of glioblastoma cancer using novel
    Loft MD; Sun Y; Liu C; Christensen C; Huang D; Kjaer A; Cheng Z
    Amino Acids; 2017 Jun; 49(6):1089-1100. PubMed ID: 28316028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma.
    Persson M; Nedergaard MK; Brandt-Larsen M; Skovgaard D; Jørgensen JT; Michaelsen SR; Madsen J; Lassen U; Poulsen HS; Kjaer A
    J Nucl Med; 2016 Feb; 57(2):272-8. PubMed ID: 26429955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts.
    Shen Y; Pi Z; Yan F; Yeh CK; Zeng X; Diao X; Hu Y; Chen S; Chen X; Zheng H
    Int J Nanomedicine; 2017; 12():5613-5629. PubMed ID: 28848341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors.
    Oxboel J; Brandt-Larsen M; Schjoeth-Eskesen C; Myschetzky R; El-Ali HH; Madsen J; Kjaer A
    Nucl Med Biol; 2014 Mar; 41(3):259-67. PubMed ID: 24417983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary, Selective PET Imaging of Integrin Subtypes α5β1 and αvβ3 Using 68Ga-Aquibeprin and 68Ga-Avebetrin.
    Notni J; Steiger K; Hoffmann F; Reich D; Kapp TG; Rechenmacher F; Neubauer S; Kessler H; Wester HJ
    J Nucl Med; 2016 Mar; 57(3):460-6. PubMed ID: 26635338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
    Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
    Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting VPAC1 Receptors for Imaging Glioblastoma.
    Tripathi SK; Kean R; Bongiorno E; Hooper DC; Jin YY; Wickstrom E; McCue PA; Thakur ML
    Mol Imaging Biol; 2020 Apr; 22(2):293-302. PubMed ID: 31292914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of experimental BT4C glioma models for somatostatin receptor 2-targeted therapies.
    Kiviniemi A; Gardberg M; Autio A; Li XG; Heuser VD; Liljenbäck H; Käkelä M; Sipilä H; Kurkipuro J; Ylä-Herttuala S; Knuuti J; Minn H; Roivainen A
    Acta Oncol; 2014 Aug; 53(8):1125-34. PubMed ID: 24957558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and validation of integrin α2β1-targeted probe for microPET imaging of prostate cancer.
    Huang CW; Li Z; Cai H; Chen K; Shahinian T; Conti PS
    Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1313-22. PubMed ID: 21350963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.
    Haubner R; Wester HJ; Burkhart F; Senekowitsch-Schmidtke R; Weber W; Goodman SL; Kessler H; Schwaiger M
    J Nucl Med; 2001 Feb; 42(2):326-36. PubMed ID: 11216533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative kinetics of [124I]FIAU in cat and man.
    Jacobs A; Bräunlich I; Graf R; Lercher M; Sakaki T; Voges J; Hesselmann V; Brandau W; Wienhard K; Heiss WD
    J Nucl Med; 2001 Mar; 42(3):467-75. PubMed ID: 11337525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing Boron Uptake in Brain Glioma by a Boron-Polymer/Microbubble Complex with Focused Ultrasound.
    Fan CH; Wang TW; Hsieh YK; Wang CF; Gao Z; Kim A; Nagasaki Y; Yeh CK
    ACS Appl Mater Interfaces; 2019 Mar; 11(12):11144-11156. PubMed ID: 30883079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (68)Ga-PRGD2 PET/CT in the evaluation of Glioma: a prospective study.
    Li D; Zhao X; Zhang L; Li F; Ji N; Gao Z; Wang J; Kang P; Liu Z; Shi J; Chen X; Zhu Z
    Mol Pharm; 2014 Nov; 11(11):3923-9. PubMed ID: 25093246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.